Micrornas in the cancer clinic

Frontiers in Bioscience - Elite

Volumn 5 E, Issue 1, 2013, Pages 204-213

  Krell, Jonathan ^a   Frampton, Adam E ^a   Stebbing, Justin ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Biomarkers; Cancer; Mirnas; Review; Therapeutics

Indexed keywords

ALPHA INTERFERON; ANTAGOMIR; ANTAGOMIR 182; ANTAGOMIR 221; ANTAGOMIR 222; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CISPLATIN; FLUDARABINE; FLUOROURACIL; GEMCITABINE; MICRORNA; MICRORNA 122; MICRORNA 155; MIRAVIRSEN; NANOPARTICLE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; TUMOR MARKER;

ACUTE GRANULOCYTIC LEUKEMIA; ADENO ASSOCIATED VIRUS; ARTICLE; BREAST CANCER; CANCER CENTER; CANCER INHIBITION; CANCER PROGNOSIS; CANCER THERAPY; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; LUNG CANCER; MELANOMA; NEOPLASM; NONHUMAN; OBESITY; ONCOGENE; OVARY CANCER; PANCREAS CANCER; PATHOGENESIS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PROSTATE CANCER; RNA INTERFERENCE; SINGLE DRUG DOSE; TUMOR SUPPRESSOR GENE; VIREMIA; XENOGRAFT; DRUG ANTAGONISM; GENE TRANSFER; REVIEW;

GENE TRANSFER TECHNIQUES; HUMANS; MICRORNAS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84878509214     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e608     Document Type: Article

References (86)

1. DP Bartel: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116(2), 281-97 (2004)
2. DP Bartel: MicroRNAs: target recognition and regulatory functions. Cell, 136(2), 215-33 (2009)
3. GA Calin, C Sevignani, CD Dumitru, T Hyslop, E Noch, S Yendamuri, M Shimizu, S Rattan, F Bullrich, M Negrini and CM Croce: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A, 101(9), 2999-3004 (2004) (Pubitemid 38327724)
4. A Ventura and T Jacks: MicroRNAs and cancer: short RNAs go a long way. Cell, 136(4), 586-91 (2009)
5. GA Calin, CD Dumitru, M Shimizu, R Bichi, S Zupo, E Noch, H Aldler, S Rattan, M Keating, K Rai, L Rassenti, T Kipps, M Negrini, F Bullrich and CM Croce: Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A, 99(24), 15524-9 (2002) (Pubitemid 35403967)
6. N Yanaihara, N Caplen, E Bowman, M Seike, K Kumamoto, M Yi, RM Stephens, A Okamoto, J Yokota, T Tanaka, GA Calin, CG Liu, CM Croce and CC Harris: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 9(3), 189-98 (2006) (Pubitemid 43357945)
7. GV Gee, DC Koestler, BC Christensen, DJ Sugarbaker, D Ugolini, GP Ivaldi, MB Resnick, EA Houseman, KT Kelsey and CJ Marsit: Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma. Int J Cancer, 127(12), 2859-69 (2010)
8. M Fassan, K Sachsenmeir, M Rugge and R Baffa: Role of miRNA in distinguishing primary brain tumors from secondary tumors metastatic to the brain. Front Biosci (Schol Ed), 3, 970-9 (2011)
9. Y Murakami, T Yasuda, K Saigo, T Urashima, H Toyoda, T Okanoue and K Shimotohno: Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene, 25(17), 2537-45 (2006)
10. MV Iorio, M Ferracin, CG Liu, A Veronese, R Spizzo, S Sabbioni, E Magri, M Pedriali, M Fabbri, M Campiglio, S Menard, JP Palazzo, A Rosenberg, P Musiani, S Volinia, I Nenci, GA Calin, P Querzoli, M Negrini and CM Croce: MicroRNA gene expression deregulation in human breast cancer. Cancer Res, 65(16), 7065-70 (2005) (Pubitemid 41161233)
11. C Roldo, E Missiaglia, JP Hagan, M Falconi, P Capelli, S Bersani, GA Calin, S Volinia, CG Liu, A Scarpa and CM Croce: MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol, 24(29), 4677-84 (2006) (Pubitemid 46630931)
12. X Chen, Y Ba, L Ma, X Cai, Y Yin, K Wang, J Guo, Y Zhang, J Chen, X Guo, Q Li, X Li, W Wang, J Wang, X Jiang, Y Xiang, C Xu, P Zheng, J Zhang, R Li, H Zhang, X Shang, T Gong, G Ning, K Zen and CY Zhang: Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res, 18(10), 997-1006 (2008)
13. S Volinia, GA Calin, CG Liu, S Ambs, A Cimmino, F Petrocca, R Visone, M Iorio, C Roldo, M Ferracin, RL Prueitt, N Yanaihara, G Lanza, A Scarpa, A Vecchione, M Negrini, CC Harris and CM Croce: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A, 103(7), 2257-61 (2006) (Pubitemid 43271657)
14. D Zheng, S Haddadin, Y Wang, LQ Gu, MC Perry, CE Freter and MX Wang: Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int J Clin Exp Pathol, 4(6), 575-86 (2011)
15. J Shen, Z Liu, NW Todd, H Zhang, J Liao, L Yu, MA Guarnera, R Li, L Cai, M Zhan and F Jiang: Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer, 11, 374 (2011)
16. H Zhao, J Shen, L Medico, D Wang, CB Ambrosone and S Liu: A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One, 5(10), e13735 (2010)
17. J Liu, J Gao, Y Du, Z Li, Y Ren, J Gu, X Wang, Y Gong, W Wang and X Kong: Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Int J Cancer (2011)
18. K Shigehara, S Yokomuro, O Ishibashi, Y Mizuguchi, Y Arima, Y Kawahigashi, T Kanda, I Akagi, T Tajiri, H Yoshida, T Takizawa and E Uchida: Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer. PLoS One, 6(8), e23584 (2011)
19. L Yu, NW Todd, L Xing, Y Xie, H Zhang, Z Liu, H Fang, J Zhang, R L Katz and F Jiang: Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int J Cancer, 127(12), 2870-8 (2010)
20. FE Ahmed, CD Jeffries, PW Vos, G Flake, GJ Nuovo, DR Sinar, W Naziri and SP Marcuard: Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue. Cancer Genomics Proteomics, 6(5), 281-95 (2009)
21. SL Yu, HY Chen, GC Chang, CY Chen, HW Chen, S Singh, CL Cheng, CJ Yu, YC Lee, HS Chen, TJ Su, CC Chiang, HN Li, QS Hong, HY Su, CC Chen, WJ Chen, CC Liu, WK Chan, KC Li, JJ Chen and PC Yang: MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell, 13(1), 48-57 (2008) (Pubitemid 350309743)
22. L Ma, J Young, H Prabhala, E Pan, P Mestdagh, D Muth, J Teruya-Feldstein, F Reinhardt, TT Onder, S Valastyan, F Westermann, F Speleman, J Vandesompele and RA Weinberg: miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol, 12(3), 247-56 (2010)
23. SF Tavazoie, C Alarcon, T Oskarsson, D Padua, Q Wang, PD Bos, WL Gerald and J Massague: Endogenous human microRNAs that suppress breast cancer metastasis. Nature, 451(7175), 147-52 (2008)
24. S Valastyan, F Reinhardt, N Benaich, D Calogrias, AM Szasz, ZC Wang, JE Brock, AL Richardson and RA Weinberg: A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell, 137(6), 1032-46 (2009)
25. AJ Schetter, SY Leung, JJ Sohn, KA Zanetti, ED Bowman, N Yanaihara, ST Yuen, TL Chan, DL Kwong, GK. Au, CG Liu, GA. Calin, CM Croce and CC Harris: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA, 299(4), 425-36 (2008) doi:299/4/425 [pii]10. 1001/jama. 299. 4. 425 (Pubitemid 351185951)
26. AJ Schetter, GH Nguyen, ED Bowman, EA Mathe, ST Yuen, JE Hawkes, CM Croce, SY Leung and CC Harris: Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma. Clin Cancer Res, 15(18), 5878-87 (2009)
27. M Dillhoff, J Liu, W Frankel, C Croce and M Bloomston: MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J Gastrointest Surg, 12(12), 2171-6 (2008)
28. S Huang and X He: The role of microRNAs in liver cancer progression. Br J Cancer, 104(2), 235-40 (2011)
29. J Ji, J Shi, A Budhu, Z Yu, M Forgues, S Roessler, S Ambs, Y Chen, PS Meltzer, CM Croce, LX Qin, K Man, CM Lo, J Lee, IO Ng, J Fan, ZY Tang, HC Sun and XW Wang: MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med, 361(15), 1437-47 (2009)
30. T Luedde: MicroRNA-151 and its hosting gene FAK (focal adhesion kinase) regulate tumor cell migration and spreading of hepatocellular carcinoma. Hepatology, 52(3), 1164-6 (2010)
31. W Kong, L He, M Coppola, J Guo, NN Esposito, D Coppola and JQ Cheng: MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J Biol Chem, 285(23), 17869-79 (2010)
32. M Mei, Y Ren, X Zhou, XB Yuan, L Han, GX Wang, Z Jia, PY Pu, CS Kang and Z Yao: Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells. Technol Cancer Res Treat, 9(1), 77-86 (2010)
33. Z Liang, H Wu, J Xia, Y Li, Y Zhang, K Huang, N Wagar, Y Yoon, HT Cho, S Scala and H Shim: Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol, 79(6), 817-24 (2010)
34. O Kovalchuk, J Filkowski, J Meservy, Y Ilnytskyy, VP Tryndyak, VF Chekhun and IP Pogribny: Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther, 7(7), 2152-9 (2008)
35. L Castellano, G Giamas, J Jacob, RC Coombes, W Lucchesi, P Thiruchelvam, G Barton, LR Jiao, R Wait, J Waxman, GJ Hannon and J Stebbing: The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. Proc Natl Acad Sci U S A, 106(37), 15732-7 (2009)
36. JK Park, EJ Lee, C Esau and TD Schmittgen: Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma. Pancreas, 38(7), e190-9 (2009)
37. E Giovannetti, N Funel, GJ Peters, M Del Chiaro, LA Erozenci, E Vasile, LG Leon, LE Pollina, A Groen, A Falcone, R Danesi, D Campani, HM Verheul and U Boggi: MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer Res, 70(11), 4528-38 (2010)
38. JH Hwang, J Voortman, E Giovannetti, SM Steinberg, LG Leon, YT Kim, N Funel, JK Park, MA Kim, GH Kang, SW Kim, M Del Chiaro, GJ Peters and G Giaccone: Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer. PLoS One, 5(5), e10630 (2010)
39. H Yang, W Kong, L He, JJ Zhao, JD O'Donnell, J Wang, RM Wenham, D Coppola, PA Kruk, SV Nicosia and JQ Cheng: MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res, 68(2), 425-33 (2008) (Pubitemid 351380068)
40. Z Li, S Hu, J Wang, J Cai, L Xiao, L Yu and Z Wang: MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells. Gynecol Oncol, 119(1), 125-30 (2010)
41. R Eitan, M Kushnir, G Lithwick-Yanai, MB David, M Hoshen, M Glezerman, M Hod, G Sabah, S Rosenwald and H Levavi: Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients. Gynecol Oncol, 114(2), 253-9 (2009)
42. M Ferracin, B Zagatti, L Rizzotto, F Cavazzini, A Veronese, M Ciccone, E Saccenti, L Lupini, A Grilli, C De Angeli, M Negrini and A Cuneo: MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia. Mol Cancer, 9, 123 (2010)
43. E Moussay, V Palissot, L Vallar, HA Poirel, T Wenner, V El Khoury, N Aouali, K Van Moer, B Leners, F Bernardin, A Muller, P Cornillet-Lefebvre, A Delmer, C Duhem, F Ries, E van Dyck and G Berchem: Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia. Mol Cancer, 9, 115 (2010)
44. S Shimizu, T Takehara, H Hikita, T Kodama, T Miyagi, A Hosui, T Tatsumi, H Ishida, T Noda, H Nagano, Y Doki, M Mori and N Hayashi: The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. J Hepatol, 52(5), 698-704 (2010)
45. ML Yeung and KT Jeang: MicroRNAs and Cancer Therapeutics. Pharm Res, 28(12), 3043-9 (2011)
46. AG Bader, D Brown, J Stoudemire and P Lammers: Developing therapeutic microRNAs for cancer. Gene Ther, 18, 1121-1126 (2011)
47. SP Nana-Sinkam and CM Croce: MicroRNAs as therapeutic targets in cancer. Transl Res, 157(4), 216-25 (2011)
48. E Song, SK Lee, J Wang, N Ince, N Ouyang, J Min, J Chen, P Shankar and J Lieberman: RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med, 9(3), 347-51 (2003) (Pubitemid 36362792)
49. J Krutzfeldt, N Rajewsky, R Braich, KG Rajeev, T Tuschl, M Manoharan and M Stoffel: Silencing of microRNAs in vivo with 'antagomirs'. Nature, 438(7068), 685-9 (2005)
50. L Ma, J Teruya-Feldstein and RA Weinberg: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature, 449(7163), 682-8 (2007) (Pubitemid 47552092)
51. F Felicetti, MC Errico, L Bottero, P Segnalini, A Stoppacciaro, M Biffoni, N Felli, G Mattia, M Petrini, MP Colombo, C Peschle and A Care: The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res, 68(8), 2745-54 (2008) (Pubitemid 351556272)
52. C Huynh, MF Segura, A Gaziel-Sovran, S Menendez, F Darvishian, L Chiriboga, B Levin, D Meruelo, I Osman, J Zavadil, EG Marcusson and E Hernando: Efficient in vivo microRNA targeting of liver metastasis. Oncogene, 30(12), 1481-8 (2011)
53. RE Lanford, ES Hildebrandt-Eriksen, A Petri, R Persson, M Lindow, ME Munk, S Kauppinen and H Orum: Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science, 327(5962), 198-201 (2010)
54. D Haussecker and MA Kay: miR-122 continues to blaze the trail for microRNA therapeutics. Mol Ther, 18(2), 240-2 (2010)
55. B Gentner, G Schira, A Giustacchini, M Amendola, BD Brown, M Ponzoni and L Naldini: Stable knockdown of microRNA in vivo by lentiviral vectors. Nat Methods, 6(1), 63-6 (2009)
56. F Takeshita, L Patrawala, M Osaki, RU Takahashi, Y Yamamoto, N Kosaka, M Kawamata, K Kelnar, AG Bader, D Brown and T Ochiya: Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol Ther, 18(1), 181-7 (2010)
57. P Gandellini, V Profumo, M Folini and N Zaffaroni: MicroRNAs as new therapeutic targets and tools in cancer. Expert Opin Ther Targets, 15(3), 265-79 (2011)
58. J Kota, RR Chivukula, KA O'Donnell, EA Wentzel, CL Montgomery, HW Hwang, TC Chang, P Vivekanandan, M Torbenson, KR Clark, JR Mendell and JT Mendell: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell, 137(6), 1005-17 (2009)
59. P Trang, PP Medina, JF Wiggins, L Ruffino, K Kelnar, M Omotola, R Homer, D Brown, AG Bader, JB Weidhaas and FJ Slack: Regression of murine lung tumors by the let-7 microRNA. Oncogene, 29(11), 1580-7 (2010)
60. A Esquela-Kerscher, P Trang, JF Wiggins, L Patrawala, A Cheng, L Ford, JB Weidhaas, D Brown, AG Bader and FJ Slack: The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle, 7(6), 759-64 (2008) (Pubitemid 351520040)
61. ME Davis, JE Zuckerman, CH Choi, D Seligson, A Tolcher, CA Alabi, Y Yen, JD Heidel and A Ribas: Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature, 464(7291), 1067-70 (2010)
62. LM McShane, DG Altman, W Sauerbrei, SE Taube, M Gion and GM Clark: REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer, 93(4), 387-91 (2005) (Pubitemid 43080010)
63. F Andre, LM McShane, S Michiels, DF Ransohoff, DG Altman, JS Reis-Filho, DF Hayes and L Pusztai: Biomarker studies: a call for a comprehensive biomarker study registry. Nat Rev Clin Oncol, 8(3), 171-6 (2011)
64. LX Yan, XF Huang, Q Shao, MY Huang, L Deng, QL Wu, YX Zeng and JY Shao: MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA, 14(11), 2348-60 (2008)
65. K Kim, G Chadalapaka, SO Lee, D Yamada, X Sastre-Garau, PA Defossez, YY Park, JS Lee and S Safe: Identification of oncogenic microRNA-17-92/ZBTB4/ specificity protein axis in breast cancer. Oncogene (2011)
66. F Yu, H Yao, P Zhu, X Zhang, Q Pan, C Gong, Y Huang, X Hu, F Su, J Lieberman and E Song: let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell, 131(6), 1109-23 (2007) (Pubitemid 350235025)
67. N Valeri, P Gasparini, M Fabbri, C Braconi, A Veronese, F Lovat, B Adair, I Vannini, F Fanini, A Bottoni, S Costinean, SK Sandhu, GJ Nuovo, H Alder, R Gafa, F Calore, M Ferracin, G Lanza, S Volinia, M Negrini, MA McIlhatton, D Amadori, R Fishel and CM Croce: Modulation of mismatch repair and genomic stability by miR-155. Proc Natl Acad Sci U S A, 107(15), 6982-7 (2010)
68. IA Asangani, SA Rasheed, DA Nikolova, JH Leupold, NH Colburn, S Post and H Allgayer: MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene, 27(15), 2128-36 (2008) (Pubitemid 351485639)
69. O Slaby, M Svoboda, J Michalek and R Vyzula: MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer, 8, 102 (2009)
70. M Seike, A Goto, T Okano, ED Bowman, AJ Schetter, I Horikawa, EA Mathe, J Jen, P Yang, H Sugimura, A Gemma, S Kudoh, CM Croce and CC Harris: MiR-21 is an EGFRregulated anti-apoptotic factor in lung cancer in neversmokers. Proc Natl Acad Sci U S A, 106(29), 12085-90 (2009)
71. Y Hayashita, H Osada, Y Tatematsu, H Yamada, K Yanagisawa, S Tomida, Y Yatabe, K Kawahara, Y Sekido and T Takahashi: A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res, 65(21), 9628-32 (2005) (Pubitemid 41541436)
72. MW Nasser, J Datta, G Nuovo, H Kutay, T Motiwala, S Majumder, B Wang, S Suster, ST Jacob and K Ghoshal: Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J Biol Chem, 283(48), 33394-405 (2008)
73. J Jiang, Y Gusev, I Aderca, TA Mettler, DM Nagorney, DJ Brackett, LR Roberts and TD Schmittgen: Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res, 14(2), 419-27 (2008) (Pubitemid 351226109)
74. F Meng, R Henson, H Wehbe-Janek, K Ghoshal, ST Jacob and T Patel: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 133(2), 647-58 (2007) (Pubitemid 47187346)
75. J Ding, S Huang, S Wu, Y Zhao, L Liang, M Yan, C Ge, J Yao, T Chen, D Wan, H Wang, J Gu, M Yao, J Li, H Tu and X He: Gain of miR-151 on chromosome 8q24. 3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat Cell Biol, 12(4), 390-9 (2010)
76. S Zhu, H Wu, F Wu, D Nie, S Sheng and YY Mo: MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res, 18(3), 350-9 (2008) (Pubitemid 351333899)
77. C Liu, K Kelnar, B Liu, X Chen, T Calhoun-Davis, H Li, L Patrawala, H Yan, C Jeter, S Honorio, JF Wiggins, AG Bader, R Fagin, D Brown and DG Tang: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med, 17(2), 211-5 (2011)
78. D Bonci, V Coppola, M Musumeci, A Addario, R Giuffrida, L Memeo, L D'Urso, A Pagliuca, M Biffoni, C Labbaye, M Bartucci, G Muto, C Peschle and R De Maria: The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med, 14(11), 1271-7 (2008)
79. C Clape, V Fritz, C Henriquet, F Apparailly, PL Fernandez, F Iborra, C Avances, M Villalba, S Culine and L Fajas: miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice. PLoS One, 4(10), e7542 (2009)
80. Q Ji, X Hao, M Zhang, W Tang, M Yang, L Li, D Xiang, JT Desano, GT Bommer, D Fan, ER Fearon, TS Lawrence and L Xu: MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One, 4(8), e6816 (2009)
81. J Torrisani, B Bournet, MC du Rieu, M Bouisson, A Souque, J Escourrou, L Buscail and P Cordelier: let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. Hum Gene Ther, 20(8), 831-44 (2009)
82. YC Han, CY Park, G Bhagat, J Zhang, Y Wang, JB Fan, M Liu, Y Zou, IL Weissman and H Gu: microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J Exp Med, 207(3), 475-89 (2010)
83. R Garzon, M Garofalo, MP Martelli, R Briesewitz, L Wang, C Fernandez-Cymering, S Volinia, CG Liu, S Schnittger, T Haferlach, A Liso, D Diverio, M Mancini, G Meloni, R Foa, MF Martelli, C Mecucci, CM Croce and B Falini: Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci U S A, 105(10), 3945-50 (2008) (Pubitemid 351723504)
84. R Garzon, CE Heaphy, V Havelange, M Fabbri, S Volinia, T Tsao, N Zanesi, SM Kornblau, G Marcucci, GA Calin, M Andreeff and CM Croce: MicroRNA 29b functions in acute myeloid leukemia. Blood, 114(26), 5331-41 (2009)
85. K Vargova, N Curik, P Burda, P Basova, V Kulvait, V Pospisil, F Savvulidi, J Kokavec, E Necas, A Berkova, P Obrtlikova, J Karban, M Mraz, S Pospisilova, J Mayer, M Trneny, J Zavadil and T Stopka: MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia. Blood, 117(14), 3816-25 (2011)
86. T Zenz, J Mohr, E Eldering, AP Kater, A Buhler, D Kienle, D Winkler, J Durig, MH van Oers, D Mertens, H Dohner and S Stilgenbauer: miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood, 113(16), 3801-8 (2009)